0001415889-24-005092.txt : 20240223 0001415889-24-005092.hdr.sgml : 20240223 20240223172954 ACCESSION NUMBER: 0001415889-24-005092 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240221 FILED AS OF DATE: 20240223 DATE AS OF CHANGE: 20240223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Funck, Jr. Robert E. CENTRAL INDEX KEY: 0001565892 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 24672775 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD STREET 2: D-378, AP6D-2 CITY: ABBOTT PARK STATE: IL ZIP: 60064-6092 FORMER NAME: FORMER CONFORMED NAME: Funck Robert E DATE OF NAME CHANGE: 20130103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 4 1 form4-02232024_100245.xml X0508 4 2024-02-21 0000001800 ABBOTT LABORATORIES ABT 0001565892 Funck, Jr. Robert E. 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064 false true false false EXECUTIVE VICE PRESIDENT 0 Common shares without par value 2024-02-21 4 A 0 24519 0 A 222756 D Common shares without par value 20000 I By Trust Common shares without par value 20000 I By Trust Common shares without par value 18765 I Profit Sharing Trust Common shares without par value 500 I By Daughter Option (right to buy) 116.98 2024-02-21 4 A 0 92137 0 A 2025-02-21 2034-02-20 Common Shares 92137 92137 D These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. Held in daughter's annual gift trust. The reporting person disclaims beneficial ownership of all securities held by the trust. Balance in the Abbott Laboratories Stock Retirement Trust as of February 21, 2024. The reporting person disclaims beneficial ownership of all securities held by his daughter. Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 30,712 on February 21, 2025, 30,712 on February 21, 2026, and 30,713 on February 21, 2027. /s/ Robert E. Funck, Jr. by Jessica H. Paik, Attorney-in-Fact 2024-02-23